With Icahn's Prodding, Hologic Stock Could Jump

There is no shortage of reasons to dump shares of Hologic. Profits are falling, the company has a history of piling on debt, and no fewer than three CEOs have occupied the beleaguered medical equipment maker's corner office in the past 12 months.

It's not a picture that inspires investor confidence. For years, Hologic (ticker: HOLX), which makes mammography machines, laboratory equipment and surgical tools, has been under fire by analysts and investors who say the company's stock price has underperformed due to...